Breaking News on Drug DiscoveryDaily
Monday 06 August 2007
Forward to a colleague |
|
|
| Breaking News on Drug Discovery |
||
|
||
| Daily
Monday 06 August 2007 |
Forward to a colleague |
|
|
Sponsored Message  Adenoviral shRNA and cDNA collectionsAs the business service unit for Galapagos, a leading genomics-based drug discovery company, BioFocus DPI offers superior adenoviral tools and services to meet your target discovery and validation needs... Click Here Access Full Stories  Pfizer's GORD therapy enters the clinicPfizer has initiated a Phase I study for its gastro oesophageal reflux disease (GORD or GERD using the US spelling) therapy that it licensed from Kosan Biosciences, in a deal worth up to $250m (€181m)... Read Entelos to develop liver injury model for the FDA The search for better models to predict drug-induced human liver damage has led the FDA (US Food and Drug Administration) to turn to Entelos to design a 'virtual liver' to guide biomarker and assay development... Read PharmaNet back in the red; lawsuit settled PharmaNet has reported second quarter results that place it back in the red after it had only just clawed its way back into the black in the first quarter, following a string of quarterly losses... Read Asuragen moves ahead with microRNA offering Asuragen has launched a newly expanded miRNA expression profiling service that can search over 13,000 human candidate miRNAs... Read How does HIV cause AIDS? Remarkably, despite being over 25 years into the HIV/AIDS epidemic, scientists still don't have an answer to the seemingly simple question: how does HIV cause AIDS?... Read |
|
||||||||
All News Headlines for: August | July | June |
||||||||||
 Product OverviewPre-Clinical Contract Research - Free Download Pharmatest offers unique preclinical in vitro and in vivo drug efficacy testing services to pharmaceutical companies developing new drugs against osteoporosis, cancer or osteoarthritis. Our services can also be used for testing existing compounds for possible adverse effects on bone or secondary indication for bone-related diseases, as well as development of functional foods for bone health... Click Here |
||||||||||
|
Related Industry News Skyepharma forced to delay NDA in US SkyePharma will be delaying its New Drug Application (NDA) in the US for its asthma treatment Flutiform following an "unexpected" setback in the submission process... Read Viagra, Cialis imitations seized in London raid In the latest episode of illegal drug trading, a hoard of unlicensed medicines was seized by the UK Medicines and Healthcare products Regulatory Agency (MHRA) last week, taken from a London lock-up containing a... Read Allegra and BMS deal boost AMRI Q2 profit Albany Molecular Research Inc. (AMRI) has posted encouraging financial results in the second quarter of the year, boosted by both bigger royalty payments and steady growth in its contract business... Read Lonza pushes biopharma portfolio Switzerland-based Lonza is establishing its biopharma portfolio with the acquisition of Zyentia's Aggresolve technology this week... Read
|
||||||||||
|
|||
| Forward to a colleague |
|||
|
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
|
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||
